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Abstract
Sonic Hedgehog (Shh) plays an instrumental role in brain development, fine-tuning processes such as cell proliferation, 
patterning, and fate specification. Although, mutations in the SHH pathway in humans are associated with various neurode-
velopmental disorders, ranging from holoprosencephaly to schizophrenia, its expression pattern in the developing human 
brain is not well established. We now determined the previously not reported wide expression of SHH in the human fetal 
cerebral cortex during most of the gestation period (10–40 gestational weeks). This spatiotemporal distribution puts Shh in 
a position to influence the fundamental processes involved in corticogenesis. SHH expression increased during development, 
shifting from progenitor cells in the proliferative zones to neurons, both glutamatergic and GABAergic, and astrocytes in 
upper cortical compartments. Importantly, the expression of its downstream effectors and complementary receptors revealed 
evolutionary differences in SHH-pathway gene expression between humans and rodents.
Keywords Cerebral cortex · Human fetal brain · Morphogen · SHH receptors
Introduction
Corticogenesis is a developmental process that requires 
coordination of the signaling pathways providing mitogenic 
signals and guiding the regulation of symmetric/asymmetric 
divisions of neuronal progenitors, positional information, 
differentiation signals, and a balance of excitation and inhi-
bition in the cortex. Cortical development has been exten-
sively studied in mice, and although it is considered to be 
generally well conserved in mammals, a number of changes 
and novelties have emerged during evolution that may 
underlie the biological basis for the higher cognitive and 
motor abilities that are specific to humans (Geschwind and 
Rakic 2013; Silbereis et al. 2016). Sonic Hedgehog (Shh) is 
a pleiotropic protein that plays a major role in most of the 
aforementioned processes during corticogenesis, including 
dorso-ventral patterning, the specification of interneurons 
and oligodendrocytes, as well as cortical circuitry forma-
tion (Fuccillo et al. 2006; Echelard et al. 1993; Ericson et al. 
1995; Xu et al. 2005; Tekki-Kessaris et al. 2001; Harwell 
et al. 2012).
During mouse embryonic development, Shh is highly 
expressed in the ventral forebrain, where it plays a criti-
cal role in patterning during a specific developmental time 
window (embryonic days 9.5–12.5) (Xu et al. 2005; Fuccillo 
et al. 2004; Machold et al. 2003). Notably, changes in the 
concentration of Shh and the duration of Shh exposure influ-
ence the specification of different ventral progenitors and 
their neuronal progeny, which range from hypothalamic and 
striatal projection neurons to cortical and striatal interneu-
rons (Maroof et al. 2013; Tyson et al. 2015). Despite the 
sparse expression of Shh in the mouse dorsal telencephalon 
(Dahmane et al. 2001), conditional inactivation of the Shh 
pathway leads to the defective proliferation of intermediate 
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progenitor cells and to microcephaly (Komada et al. 2008). 
These results point to the concentration-dependent func-
tions of this morphogen in both dorsal and ventral forebrain 
developments.
The significance of SHH in human brain development is 
illustrated by the dramatic consequences of SHH-pathway 
gene disruption, which include holoprosencephaly, seizure 
disorders, language or cognitive impairment, Down syn-
drome, hyperactivity, and schizophrenia (Heussler et al. 
2002; Nanni et al. 1999; Belloni et al. 1996; Odent et al. 
1999; Santiago et al. 2006; Currier et al. 2012; Betcheva 
et al. 2013). Many of these conditions are the result of SHH 
haploinsufficiency, thus highlighting the importance of SHH 
gene dosage in humans (Chiang et al. 1996). Although in 
human embryos (Carnegie stages 12–16), the expression 
of SHH has been demonstrated ventrally, in the notochord, 
in the floorplate of the spinal cord, and in the hindbrain 
(Odent et al. 1999; Hajihosseini et al. 1996), there is a lack 
of information regarding the sources of SHH in the develop-
ing cerebral cortex.
A prerequisite for understanding the physiological role 
of SHH signaling during cortical development is the deter-
mination of its distribution and identification of its cellular 
sources in the prenatal human cortex. Our initial results, 
obtained in vitro, showed that at mid-gestation (around 20 
gestational weeks, gw), SHH is expressed by radial glia cells 
(RGCs) and that treatment with exogenous SHH favours the 
generation of Nkx2.1+ progenitors over calretinin  (CalR+) 
cells, while it has no effect on the generation of pyrami-
dal neurons (Radonjic et al. 2016). In the present study, we 
used in situ hybridization (ISH) to analyze the distribution 
of SHH-expressing cells in the prenatal human forebrain. We 
studied a wide spectrum of gestational ages (8–40 gw), using 
cryo-sections from throughout the rostro-caudal brain axis. 
We also combined fluorescence ISH (FISH) with cell-type-
specific immunostaining and identified the cell types that 
express this morphogen. Finally, we analyzed, for the first 
time, the expression pattern of the known SHH receptors and 
downstream effectors in comparison with SHH expression in 
the early and late corticogenesis. These results contribute to 
the better understanding of cortical development and point 
to the importance of further studies of SHH signaling in 
neuropsychiatric disorders.
Materials and methods
Human fetal brain tissue
Human fetal brains (n = 30) from 8 to 40 gw (gestational 
weeks correspond to postconceptional weeks; full term = 40 
gw) (Table S1) were obtained from the Human Fetal Tis-
sue Repository at the Albert Einstein College of Medicine 
(Bronx), Advanced Bioscience Resources (Alameda, CA), 
StemEx (Diamond Springs, CA, USA) and the joint MRC/
Wellcome Trust-funded Human Developmental Biology 
Resource (http://www.hdbr.org) after legal abortions with 
appropriate maternal written consent and approval from 
the Ethics Committees of the participating institutions. All 
human materials were handled with special care and follow-
ing all necessary requirements and regulations set by the 
Ethics Committee of the University of Connecticut and the 
Helsinki Declaration. Fetal age was estimated on the basis 
of weeks after last period, crown-rump length, and anatomi-
cal landmarks. In all studied fetuses, ultrasound and gross 
neuropathological examination were used to exclude those 
with brain pathology. The dissected tissues were fixed in 4% 
formaldehyde solution in 0.1 M phosphate buffer, cryopro-
tected by immersion in 30% sucrose, embedded in Tissue 
Tek (Sakura), frozen, and preserved in − 80 °C until needed. 
The tissues used for in situ hybridization (ISH) and immuno-
histochemistry were cut into 15-µm-thick sections.
In situ hybridization
The human full-coding sequences (CDS) for GLI1, GLI2, 
GLI3, and PTCH 1 were purchased from Dharmacon. The 
human SHH CDS was a gift from Cliff Tabin (Marigo et al. 
1995) (pBS hShh CT#401 Addgene # 13996). For the SMO, 
BOC, GAS1, and CDON probes, cDNAs from human fetal 
brain (18 gw) were used as templates. The riboprobes were 
generated from a PCR fragment containing the transcrip-
tion promoter sites T3/T7/SP6 (see Table S2), by in vitro 
transcription using digoxigenin (DIG)-UTP (Roche) as the 
label. ISH was performed as previously described (Radonjic 
et al. 2014). Briefly, cryo-sections (15 µm) were dried at 
room temperature (RT) for 2 h, fixed for 10 min with 4% 
paraformaldehyde (PFA), and washed twice in diethyl pyro-
carbonate (DEPC)-treated phosphate buffer solution (PBS) 
before overnight incubation at 70 °C in hybridization buffer 
containing 1 × DEPC-treated “salts” (200 mM NaCl, 5 mM 
EDTA, 10 mM Tris, pH 7.5, 5 mM NaH2PO4·2H2O, 5 mM 
Na2HPO4; Sigma-Aldrich), 50% deionized formamide 
(Roche), 0.1 mg/mL of RNase-free yeast tRNA (Invitrogen, 
Carlsbad, CA, USA), 1 × Denhardts (RNase/DNase-free; 
Invitrogen), 10% dextran sulfate (Sigma-Aldrich) containing 
100–500 ngmL of digoxigenin (DIG)-labeled RNA probe. 
After hybridization, the sections were washed three times 
in a solution containing 50% formamide 1 × SSC (saline-
sodium citrate, Invitrogen) and 0.1% Tween 20 (Sigma-
Aldrich) at 65 °C, and twice at RT in 1 × MABT (20 mM 
maleic acid, 30 mM NaCl, 0.1% Tween 20; Sigma-Aldrich) 
before incubating in a solution containing 2% blocking 
reagent (Roche) and 10% heat-inactivated sheep serum in 
MABT, followed by overnight incubation in alkaline-phos-
phatase-conjugated anti-DIG antibody (1:1500; Roche). 
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Fast Red (Roche) was used for the fluorescent colorimetric 
detection of probe (FISH) by incubation in 100 mM Tris, 
pH 8.2, 400 mM NaCl containing Fast Red for 1–2 h at 
37 °C. Alternatively, the TSA (tyramide signal amplifica-
tion) kit (Perkinelmer) was used for FISH, in combination 
with anti-DIG-POD antibody (1:500, Roche). The sections 
were counterstained with bis-benzimide and cover-slipped 
using Fluoromount G mounting medium. The specificity of 
the procedure was assessed with a probe corresponding to 
the sense strand of the respective genes.
Immunohistochemistry after ISH
After ISH, sections were subjected to antigen retrieval in 
0.1 M citric acid, pH 9.0, and blocked in 10% normal goat 
serum (NGS)/PBS containing 0.2% Triton (PBST). Fol-
lowing overnight incubation with primary antibody (see 
Table S3 for details), the sections were thoroughly washed 
in PBST and incubated with secondary Alexa 488- or Alexa 
555-conjugated antibodies (Life Technologies) for 2 h at 
RT. Alternatively, an ABC kit was used followed by DAB 
development. Nuclei were counterstained for 5 min at RT 
with the nuclear stain bis-benzimide (Sigma).
Quantification of immunolabeled cells
Immunolabeled sections were visualized with an Axioscope 
microscope (Zeiss) equipped with Axiovision software and 
photographed using a digital camera. Three samples (22–24 
gw) were used for the quantifications presented in Figs. 4 
and 5. Nuclear staining allowed the delineation of areas of 
interest (e.g., CP, SVZ, IZ, and GE). Ten images for each 
region of interest were observed at 40× magnification and 
the number of cells was counted using the Photoshop CS6 
Count Tool. A descriptive analysis of the data was per-
formed using the Excel Data analysis plug-in. The percent-
ages of double-positive cells expressing SHH are presented 
together with the standard error of the mean (SEM).
Results
Distribution of SHH mRNA in the developing human 
forebrain
Detailed information on the spatial distribution of SHH in 
the human developing brain is lacking, in part due to the 
limited availability of tissue and the failure of most commer-
cially available antibodies to label SHH. We thus used ISH 
against the human coding sequence of SHH to follow expres-
sion during 7 months of the human gestational period (8–40 
gw; Table S1). The expression of SHH was highly dynamic, 
in accordance with the transcriptomics data available from 
the Allen Brain Institute (Fig. S1a, b). SHH expression in the 
fetal forebrain increased over the course of development and 
shifted from the proliferative ventricular (VZ) and subven-
tricular zones (SVZ) (Fig. 1) to the overlying cortical layers 
(Fig. 2). At the earliest age studied (8–10 gw), Shh mRNA 
was predominantly restricted to the ventral forebrain, includ-
ing the midline of the hypothalamus and thalamus, and to 
the emerging basal ganglia (Fig. 1a, e, f), in a similar pattern 
detected in the early embryonic mouse brain (Fig. S6a). By 
contrast, SHH mRNA was only weakly expressed dorsally, 
in the cortical plate (CP) and cortical VZ (Fig. 1a, b), a result 
confirmed by TSA-FISH (tyramide signal amplification) and 
the absence of a signal with the sense probe (Fig. 1g′ and 
S5). Furthermore, immunostaining with the rabbit mono-
clonal anti-SHH antibody (Farmer et al. 2016) revealed the 
definite presence of SHH protein in this area (Fig. 1g, g′′ 
and Fig. S1c–c′′). The proximal choroid plexus (ChP) was 
also positive for the SHH transcript and protein (Fig. 1h–h′′). 
Notably, the levels of SHH were much higher in ChP cells 
than in the nearby VZ, as observed by the differences in 
signal intensity at the different exposure times/settings (Fig. 
S1c–c′′). Thus, it cannot be ruled out that the positive signal 
for the SHH protein in the cortical VZ reflected the uptake of 
ChP-secreted SHH by RGCs. However, SHH immunostain-
ing in the cortical VZ appeared in more frontal sections that 
are much further from the ChP (not present in the same sec-
tion), suggesting that SHH is produced locally.
Another source of SHH protein in the developing human 
brain at this stage is the meninges, which were strongly 
positive for SHH mRNA and protein. Within the meninges, 
SHH-expressing cells were those of smooth-muscle lineage, 
rather than fibroblasts, as demonstrated by co-localization 
with smooth-muscle actin but not vimentin antibody (Fig. 1j, 
k). Finally, SHH mRNA was detected in the endothelial cells 
of blood vessels in the GE stained for the endothelial cell 
marker PECAM (CD31), indicating that the developing 
vasculature is an additional source of SHH (Fig. S1d–d′′). 
Notably, endothelial cells in the ChP did not express SHH 
(Fig. 1i). Extracortically, SHH mRNA co-localized with 
SHH protein in the hypothalamic midline and retinal gan-
glion cells. In addition to validating the specificity of the 
antibody, this result provided insight into the range of SHH 
diffusion from its source (Fig. S1e–e′′, f–f′′).
In the subsequent stages of development (15–17 gw), the 
density and distribution of SHH transcripts increased con-
siderably throughout the forebrain (Fig. 2a, b; Fig. S2a). 
Strong signal was detected not only in the cortical VZ/SVZ 
(Fig. 2a′′′, b′′; Fig. S2a), but also in the cortical plate (CP) 
(Fig. 2a′, b; Fig. S2a), whereas the signal in the intermediate 
zone (IZ) and subplate (SP) increased dramatically from 15 
to 17 gw (Fig. 2a′, b′).
In the next stage of development, at mid-gestation (18–24 
gw), SHH expression increased steadily in subpopulations of 
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cells in the expanded outer SVZ (oSVZ) (Figs. 3a, 6f), and 
in the IZ and SP, the zones through which neurons migrate 
(Figs. 2, 3a). At the same time, a very strong signal was 
present in cells located in the ganglionic eminence (GE) 
and hippocampus (Fig. 6j, S7c and Fig. S3). From 24 gw 
onwards, the SHH transcript signal in the cVZ decreased 
progressively, coinciding with a reduction in the size of 
these structures in late fetal development. This is the first 
study demonstrating SHH expression in the GE and cVZ| 
in stages after 14 gw. SHH expression in the upper cortical 
layers remained high between 24 and 27 gw and persisted in 
the newborn (40 gw), in which SHH-expressing cells were 
found in all layers of the cerebral cortex (Fig. 2) and in the 
hippocampus (Fig. S3). A similar expression pattern was 
detected in mouse postnatal day 4 (P4) brain (Fig.S7d–d′′).
We then examined whether SHH transcripts were pre-
sent uniformly along the rostro-caudal and dorso-ventral 
axis or formed a gradient in these regions of the human 
fetal cortex. ISH performed in sagittal sections of 15-gw 
forebrain showed that, although SHH expression appeared 
slightly higher in the rostral and caudal cortical areas than 
in the dorsal and ventral areas, the difference over the entire 
cortex was not significant (Fig. S2).
However, in later developmental stages (21–24 gw), SHH 
expression exhibited a high rostral to lower caudal gradi-
ent, as illustrated in coronal sections prepared from rostral 
(frontal), medial, and caudal (occipital) tissue blocks of the 
23-gw fetal forebrain (Fig. 3a). Moreover, within each tis-
sue block, SHH signal intensity was consistently stronger in 
dorsal than in ventral cortical areas (Fig. 3a).
In addition, cortical SHH expression exhibited regional 
differences, as illustrated in single coronal sections pre-
pared through the level of the thalamus. The signal was 
always stronger above the insular region of the cortex, in 
the prospective somatosensory/motor cortices and possibly 
including Broca’s area (Fig. 3b:1–4), than in the ventrally 
Fig. 1  Expression of Sonic Hedgehog (SHH) in the human brain at 10 
gw. a Coronal sections through both cerebral hemispheres show SHH 
mRNA signal in the diencephalon (hypothalamus, HT) and basal gan-
glia (BG). The line indicates the midline. b Low-level SHH expres-
sion in the developing cortex, mainly in the ventricular zone (VZ) 
and cortical plate (CP). c, d Scattered cells weakly expressing Shh 
in the VZ of the ganglionic eminence (GE) (c) and in other regions 
of the GE (d). e, f High-level expression in the future basal ganglia 
(e) and hypothalamic midline (f). g–g″ Both SHH protein (green) 
and transcript (red) are demonstrated in the cortical VZ in radial glial 
cells (arrowheads). h Choroid plexus expresses SHH mRNA (red) 
and protein (green); single channels (h–h″). i Pecam (CD31) immu-
nostaining shows that endothelial cells in the choroid plexus  do not 
express  SHH mRNA. j SHH-expressing cells stain with antibody to 
smooth-muscle actin (green) but not vimentin (green) (k). Scale bars: 
a 1 mm, b, f and g 50 µm, h 20 µm
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positioned temporal cortex (Fig.  3b:6–7). This pattern, 
which first emerged around 19 gw and became prominent at 
22–24 gw, confirms the transcriptome data (Fig. S1a, b) that 
suggest higher expression in the dorsal than ventral cortex 
for this developmental stage.
These results revealed the complex pattern of SHH 
expression in the developing cortex and thus a possible role 
for SHH in cortical arealization during the second and third 
trimesters of gestation.
Characterization of SHH‑expressing cells 
during mid‑gestation
After establishing that SHH mRNA is expressed widely in 
fetal brain, we asked which cell types express SHH in the 
developing human cortex. The answer to this question is 
important, because it might indicate the roles played by SHH 
during development. We, therefore, subjected the fetal tissue 
sections to FISH followed by immunohistochemistry with 
cell-type-specific markers. Specifically, we asked whether 
during the late second trimester of gestation (20–24 gw). 
SHH transcripts are expressed by cortical progenitors, that 
is, RGCs, which are the predominant cell type in the prolif-
erative VZ/SVZ. Using the RGCs markers Pax6, GFAP, and 
vimentin, we identified cells that co-express SHH mRNA 
as well as these markers (Fig. 4). Moreover, many of the 
SHH-expressing cells were proliferating, based on their co-
labeling for the proliferation marker Ki67 (Fig. 4c). Quanti-
fication of the double-labeled cells showed that 89% (± 5.19 
SEM, n = 3) of the Pax6-positive cells in the VZ expressed 
SHH transcripts, compared to 69% (± 6.6 SEM, n = 3) in the 
SVZ; thus, at this developmental stage the majority of RGCs 
in the proliferative zones produced SHH (Fig. 4e).
Since progenitors in the fetal cortex give rise mainly to 
glutamatergic neurons, SHH-expressing cells in cortical lay-
ers were probed with the glutamatergic cell marker Tbr1 
(T-box Brain 1) to determine whether they belong to this 
neuronal population (Fig. 5a–a′′′, b). From the total popula-
tion of  Tbr1+ cells in the subplate and the IZ, around 70% 
(n = 3) were positive for SHH (Fig. 5b). Thus, in addition 
to RGCs in the VZ/SVZ, a subpopulation of glutamatergic 
neurons in cortical layers is source of SHH. This finding was 
Fig. 2  Spatiotemporal changes in SHH expression in the human cer-
ebral cortex between 15 and 40 (newborn) gw. a–f Low magnification 
of the cortical column at the indicated age. a″–f′ High magnifica-
tion of cells in the subplate (SP)/intermediate zone (IZ) area (indi-
cated boxes). a‴–e″ High magnification of cells in the cortical VZ 
(except at 40 gw,when there is no VZ). CP cortical plate. Scale bars : 
f 200 µm, f′ 50 µm
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confirmed using another marker for deep cortical layer neu-
rons, CTIP2 (Fig. 5c). Two more general neuronal markers, 
Map2 and NeuN, were also co-expressed with SHH tran-
scripts in a subpopulation of cortical neurons (Fig. 5d, e).
Co-labeling with GABA (Fig. 5f) or Gad65/67 (Fig. S4a, 
a′) suggested that at mid-gestation, cortical interneurons are 
less likely to express SHH transcript than glutamatergic neu-
rons. Since not all SHH  mRNA+ cells overlap with neuronal 
markers in higher cortical layers, we investigated whether 
non-neuronal populations in the cortex also express SHH 
transcript. Indeed,  GFAP+ astrocytes in the IZ and SP/CP 
expressed SHH (Fig. 4d), but not oligodendrocytes or micro-
glia labeled with Olig2 or Iba1, respectively (Fig. S4b, c). 
These data are consistent with a heterogeneous cell popula-
tion producing Shh during mid-gestation, with the two main 
sources being RGCs and glutamatergic neurons.
SHH‑signaling pathway in the developing human 
cortex
Despite the demonstration of the widespread expression of 
SHH in the developing human cortex, whether the classi-
cal SHH pathway was activated remained to be tested. Gli1 
(GLI zinc finger transcription factor), a transcription factor 
activated by Shh-signaling, is the most sensitive and reliable 
read-out for this pathway as, unlike Gli2 and Gli3, it acts 
only as an activator (Bai et al. 2004). The presence of GLI1 
would, therefore, provide proof that the expressed SHH acti-
vates the signaling pathway in nearby cells. ISH using the 
human GLI1 probes on sections from fetuses age 19–24 gw 
found that the GLI1 transcript was expressed in the cortical 
VZ and CP/SP as well as in the GE (Fig. 6a–d). The inten-
sity of the GE signal was much stronger, indicating a higher 
level of SHH expression, and hence SHH-signaling activity, 
in this area. GLI3, a transcription factor that acts as both a 
repressor and an activator of the Shh pathway (Ingham and 
McMahon 2001), was highly expressed in the cortical VZ, 
in the inner and outer SVZ (Fig. 6e, g–h), and in the hip-
pocampus (Fig. 6i), confirming previously published tran-
scriptomics data showing that GLI3 is expressed by human 
RGCs (Pollen et al. 2015).
We then asked whether the SHH receptor PATCHED1 
(PTCH1) is expressed in the vicinity of SHH-expressing 
cells. We tested tissues from fetuses of two gestational 
ages, early (10 gw), when cell proliferation, migration, and 
neurogenesis/fate specification are predominant, and later, 
at mid-gestation (19–24 gw), when additional processes 
such as axonal guidance and synaptogenesis occur. At 10 
gw, PTCH1 transcripts were non-detectable in the neocor-
tex (Fig. 7b, b′), while expression was low in the VZ of 
the GE and in the thalamic and hypothalamic neuroepithe-
lium, paralleling the spatiotemporal pattern of strong SHH 
expression in these ventral regions. At later stages (19–24 
gw), when SHH expression increased in the cortex, PTCH1 
was seen in the cortical VZ, although at much lower lev-
els than in ventral areas such as the GE or hypothalamus 
(Fig. 7h, h′). Immunostaining with PTCH1 antibody veri-
fied low- and high-level expression in the cortical VZ and 
GE, respectively (Fig. 7m, n). Co-labeling with GFAP also 
demonstrated the expression of this receptor by RGCs in the 
cortical VZ (Fig. 7m′). A weak PTCH1 mRNA signal was 
detected in the dentate gyrus of the hippocampus (Fig. S3h).
In addition to Ptch1, three other membrane-associated 
proteins, the structurally related Boc (biregional Cdon-
binding) and Cdon (cell-adhesion-molecule-related/down-
regulated by oncogenes) proteins and the vertebrate-only 
Gas1 (growth-arrest-specific 1) protein, are thought to func-
tion as positive modulators of Shh signaling by enhancing 
the presentation of Shh to its receptor, Ptch1 (Tenzen et al. 
2006; Allen et al. 2007; Martinelli and Fan 2007). Both Boc 
and Cdon promote Shh-dependent cell-fate specification and 
axon guidance (Tenzen et al. 2006; Okada et al. 2006), while 
Gas1 regulates the ventral specification of neural tube pro-
genitors (Allen et al. 2007; Martinelli and Fan 2007) and 
CGNP (cerebellar granule neural progenitors) prolifera-
tion (Liu et al. 2001). Boc, Gas1, and Cdon are required for 
successful Shh signaling (Izzi et al. 2011). We found that 
BOC and GAS1 were strongly expressed at 10 gw in cortical 
VZ and GE, whereas CDON was present only in the corti-
cal VZ (Fig. 7c–e). GAS1 was also expressed in the CP at 
this stage. The ChP cells, however, express only BOC at 10 
gw (Fig. S8b). At later stages (19–24 gw), the expression 
of BOC and CDON was similar to that in earlier stages: 
high in the cortical VZ and SVZ and low in the CP/SP and 
GE (Fig. 7i–i′, j–j′). GAS1 expression in the CP was lower 
than at 10 gw, but remained high in the cortical VZ, oSVZ, 
and GE (Fig. 7k–k′). Finally, expression of the SHH signal 
transducer, SMO (smoothened) was weak in the 10-gw brain 
(Fig. 7f, f′′), but increased in the 19-gw cortical VZ and in 
the CP (Fig. 7l–l′). SMO expression was also detected in the 
10-gw ChP (Fig. S8a). Thus, in summary, all three recep-
tors (BOC, CDON, and GAS1) were expressed in the VZ 
during early fetal development, pointing to their role in cell 
proliferation. CDON and GAS1 were expressed at higher 
levels than BOC in the CP, suggesting their additional roles 
in cortical development.
Fig. 3  Gradients of SHH mRNA in 23–24 gw brains. a Coronal sec-
tions from three tissue blocks (1–3) from frontal to occipital pole 
show rostro-caudal gradient of SHH mRNA expression. In addition, 
dorsal areas show higher expression than ventral in each block. b In 
a single coronal section, the expression of SHH transcripts shows 
pronounced differences (1–7). Boxed ares show higher magnifica-
tion along the cerebral cortex. 1 Cingulum; 2–3 dorsal cortex, future 
somatosensory or motor areas; 4 frontal, preinsular cortex; 5 insula; 
6–7 temporal cortex. Scale bars: a 50 µm, b 2 mm, (1) 250 µm and 
inset 50 µm
◂
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Discussion
SHH is crucial for human brain development and changes 
in its signaling lead to distinct neuropathologies (Heussler 
et al. 2002; Nanni et al. 1999; Belloni et al. 1996; Odent 
et al. 1999; Santiago et al. 2006; Currier et al. 2012). Despite 
its importance, information on SHH expression profile in 
the developing human brain is still fragmentary. Here, we 
provided evidence of the expression of SHH and the tran-
scription factors, and receptors necessary for its signaling, 
in specific cortical layers and cell types. Our study spans the 
course of most of the gestational period. The spatiotemporal 
Fig. 4  Cell-type-specific expression of SHH transcript in the 18–24-
gw fetal brain. a′–a‴ Combined ISH for SHH (red) and immunostain-
ing for Pax6 (green) show numerous radial glial cells (RGCs) that 
co-localize SHH transcript and Pax6 in the proliferative zones (VZ 
and subventricular zone, SVZ). a-inset  Higher magnification of 
co-labeled cells in the outer SVZ (oSVZ) (arrowheads). b Vimen-
tin staining for RGCs (green) after ISH for SHH (red) confirms that 
RGCs in the VZ express SHH (arrowheads). c Numerous proliferat-
ing SHH + cells, indicated by Ki67 co-expression. The inset shows a 
higher magnification of the boxed area. d Mature astrocytes  (GFAP+) 
in the IZ/SP express SHH mRNA. e Percentage of total  Pax6+ cells 
that co-express SHH (red) in the VZ (89% ±5.19 SEM) and SVZ 
(69% ± 6.6 SEM) of 22–24-gw tissues (n = 3). Scale bars: a 25 µm, 
a-inset 10 µm, a‴ 50 µm
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Fig. 5  Various subtypes of neurons express SHH in the 18–24  gw 
cortex. a–a‴ Co-labeling for SHH mRNA (red) and Tbr1 (green) 
reveals many postmitotic projection neurons across the SP and IZ 
expressing SHH. a′, a″ Single channels. b Percentage of  Tbr1+ 
cells expressing SHH in the SP (70% ±7.6 SEM) and IZ (73% ±7.8 
SEM) in 22–24-gw sections (n = 3). c–f SHH is expressed by neurons 
labeled with CTIP2 (c), MAP2 (d), NeuN (e), and GABA (f). Scale 
bars: a and a‴ 50 µm, a-inset 10 µm
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distribution suggests the involvement of SHH in diverse 
developmental processes in the human telencephalon, 
including cell proliferation and cell-fate specification in the 
VZ/SVZ, the subsequent migration of newly generated neu-
rons, synaptogenesis, and circuit formation.
Our results agree with those of the previous studies 
(Odent et  al. 1999), in which SHH mRNA was mostly 
detected in the ventral structures of the human brain during 
early stages (8–10 gw), with very low signal in the develop-
ing cerebral cortex. Given that a high concentration of SHH 
is known to induce patterning and cell-fate specification, 
whereas low levels regulate proliferation (Komada 2012; 
Komada et al. 2008; Wang et al. 2016a, b) this pattern of 
signal localization suggests that SHH regulates patterning 
and cell-fate specification in the human ventral forebrain and 
proliferation in the dorsal forebrain. SHH transcripts were 
clearly detected in the cortical VZ/SVZ at 15 gw, which is 
consistent with our previous in vitro results showing that 
this morphogen is secreted by dorsal RGCs and induces their 
proliferation (Radonjic et al. 2016). The function of Shh 
in proliferation and regulation of symmetric/asymmetric 
divisions of intermediate progenitors in mice (Dave et al. 
2011) points to a role as a mitogen in the human cortical 
proliferative zone. This role is probably maintained even 
past mid-gestation, since neurogenesis in humans continues 
up to 27 gw, later than previously known (Malik et al. 2013). 
Between 15 and 27 gw, SHH was also expressed in the IZ, 
SP, and CP, where the intensity of the signal increased over 
Fig. 6  Components of the SHH-signaling pathway are expressed in 
the human fetal cortex at 22 gw. a, b ISH reveals the cortical expres-
sion of GLI1 (CP and VZ), indicative of SHH-signaling activity in 
these areas. c, d Strong GLI1 expression in the GE suggests higher 
levels of SHH activity ventrally. e, f GLI3 and SHH transcripts show 
similar high-density signals in the VZ and oSVZ. g On higher mag-
nification,  GLI3+cells in the oSVZ resemble RGCs and are more 
numerous than in the VZ (h). i, j Comparison of the GLI3 and SHH 
expression patterns in adjacent coronal sections at the level of the 
hippocampus (Hipp) of the 22 gw fetal brain. Scale bars: f 500 µm, g 
50 µm, g- inset 15 µm, j 1 mm
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time. Furthermore, we observed robust inter-regional and 
areal differences in the expression of SHH during mid-to-
late gestation in fetal neocortex. Although it is difficult to 
interpret this spatiotemporal expression pattern, these dif-
ferences most likely have biological origin and they are not 
due to tissue quality or other variation as observed in all 
cases studied. The SHH-positive cells in developing cortical 
layers were mostly neurons expressing Map2 or NeuN, with 
a subpopulation expressing glutamatergic markers (Tbr1 
or CTIP2), as previously reported for the early postnatal 
mouse brain (Harwell et  al. 2012). The SHH transcript 
was also identified in a subpopulation of GABAergic cells, 
in accordance with the results of a single study in mouse 
(Komada et al. 2008). Given that Shh in mice plays a role in 
neuronal migration, axonal guidance (Fuccillo et al. 2006; 
Baudoin et al. 2012; Bourikas et al. 2005; Charron et al. 
2003; Yam et al. 2009), and synaptic connectivity (Harwell 
et al. 2012), it is likely that it has similar functions in the 
developing human fetal neocortex. Moreover, the finding 
that GFAP-labeled astrocytes in the upper IZ, SP, and CP 
Fig. 7  Expression of SHH receptors in the fetal human brain at 10 
and 19 gw. a–a″ ISH for SHH on a coronal section from a 10-gw 
brain, as a reference for all SHH receptors in sections from the same 
fetus. Higher magnification of the boxed areas in (a): a′ cortex, a″ 
cVZ. Weak signal is detected in the cortical VZ and GE. b–b″ ISH 
for PTCH1 receptor reveals very low expression in the VZ (b″). BOC 
expression is much more prominent along the cortical VZ and GE VZ 
(c–c″), whereas CDON expression is restricted to the cortical VZ (d–
d″). GAS1 is the only receptor expressed in both the VZ and CP, in 
addition to the GE (e–e″). SMOOTHENED (SMO) is hardly detected 
in the VZ at this stage (f–f″). g–l′ SHH and all its receptors in con-
tiguous sections of 19-gw brain. Two areas are presented for each 
gene: CP and VZ/SVZ. m Co-staining of 22-gw brain with Patched1 
and GFAP antibodies shows that RGCs in the cortical VZ express this 
receptor. m′ Higher magnification of the boxed area in (m). n Ptch1 
immunoreaction in the same section reveals a strong expression in the 
GE. a 1 mm, a′ 150 µm, a″ 25 µm
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were positive for SHH suggests a role in numerous processes 
in which astrocytes are involved, such as synapse forma-
tion and synaptic plasticity (Farmer et al. 2016; Eroglu and 
Barres 2010) as well as the formation and maintenance of 
the blood–brain barrier (BBB). Indeed, recent work demon-
strated that Hedgehog signaling promoted the formation and 
integrity of the BBB as well as the immune quiescence of 
the central nervous system (Alvarez et al. 2011). Microglia 
and oligodendrocytes were negative for SHH, but  Olig2+ 
cells were found in close proximity to SHH-expressing cells, 
which correlates well with our previous in vitro study show-
ing that SHH promotes the generation and maintenance of 
forebrain Olig2 progenitors (Ortega et al. 2013).
Our finding of GLI1 in the fetal cortical VZ and CP sug-
gests active SHH signaling in the developing human cor-
tex. This result is in line with our previous demonstration 
of functional SHH signaling in cortical RGCs in vitro, as 
indicated by the increased levels of GLI1 and PTCH1 after 
SHH treatment (Radonjic et al. 2016). In the present study, 
we provided evidence of PTCH1 (protein) as well as BOC, 
GAS1, and CDON expression in the human RGCs of the 
cortical VZ, which suggest an autocrine function for SHH 
in these progenitors. The role of these receptors has not been 
studied in cortical development, but they are known as posi-
tive modulators of Shh signaling in mice, in both cell prolif-
eration in the cerebellum (Liu et al. 2001; Izzi et al. 2011) 
and cell-fate specification in neural tube progenitors (Allen 
et al. 2007; Martinelli and Fan 2007). A recent study has 
shown that Boc, Cdon, and Gas1 are necessary components 
of the Shh receptor complex and essential in Shh signal 
transduction in vertebrates (Izzi et al. 2011). Their strong 
expression in the human cortical VZ in association with the 
low-level expression of SHH and PTCH1 during early stages 
(10 gw) suggests that they could act as enhancers of SHH 
signaling. Impaired function of BOC, CDON, and GAS1 
appears to underlie holoprosencephaly, both in humans 
(Clement et al. 2007; Ribeiro et al. 2010; Pineda-Alvarez 
et al. 2012; Bae et al. 2011) and in mice (Seppala et al. 2007; 
Zhang et al. 2006; McLellan et al. 2008). Interestingly, we 
found that BOC is strongly expressed in the human, but not 
in the mouse cortical VZ (Fig. S6, brainatlas.org), suggest-
ing a species-specific difference. Indeed, comparative epi-
genetic profiling of human, monkey, and mouse brain tissue 
identified epigenetic gains (promoters and enhancers with 
gained activity) in genes involved in human corticogenesis, 
including BOC, SHH, NKX2.1, PTCH1, and GLI3 (Reilly 
et al. 2015).
Recent studies have suggested that the transcriptional pro-
grams associated with interneuron development in human 
are very similar in the GE and cortical VZ (Miller et al. 
2014), which points to a role for SHH in interneuron fate 
specification, in addition to cell proliferation, in the cortical 
VZ. Indeed, our previous in vitro results show that SHH 
affects the commitment of some cortical RGCs to interneu-
ronal fate (Radonjic et al. 2016). This points to the need 
for a better understanding of the origin and development of 
human cortical interneurons (Radonjic et al. 2014; Alzu’bi 
et al. 2017; Clowry et al. 2010). Such studies are likely to 
provide important insights into the pathogenesis of human 
neuropsychiatric disorders such as schizophrenia, in which 
dysfunction of GABAergic interneurons has been implicated 
(Benes and Berretta 2001; Guidotti et al. 2005; Lewis et al. 
2005; Selemon and Zecevic 2015).
In conclusion, the present study fills the gap in our knowl-
edge about the presence of SHH in the developing human 
cortex which may enhance our understanding of human cor-
ticogenesis and the pathologies associated with defective 
SHH signaling.
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